Dysregulation of serum NADPH oxidase1 and ferritin levels provides insights into diagnosis of Parkinson's disease
- 1 December 2017
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 50 (18) , 1087-1092
Abstract
No abstract availableKeywords
Funding Information
- Tabriz University of Medical Sciences (95/2-4/3)
This publication has 38 references indexed in Scilit:
- The Hyperferritinemic Syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndromeBMC Medicine, 2013
- NADPH Oxidase 1-Mediated Oxidative Stress Leads to Dopamine Neuron Death in Parkinson's DiseaseAntioxidants & Redox Signaling, 2011
- Nox4 regulates Nrf2 and glutathione redox in cardiomyocytes in vivoFree Radical Biology and Medicine, 2011
- Serological Profiles of Urate, Paraoxonase-1, Ferritin and Lipid in Parkinson’s Disease: Changes Linked to Disease ProgressionNeurodegenerative Diseases, 2011
- Plasma selenium is positively related to performance in neurological tasks assessing coordination and motor speedMovement Disorders, 2010
- Could a dysfunction of ferritin be a determinant factor in the aetiology of some neurodegenerative diseases?Biochimica et Biophysica Acta (BBA) - General Subjects, 2010
- Selenoproteins and the aging brainMechanisms of Ageing and Development, 2010
- The Role of NADPH Oxidase 1–Derived Reactive Oxygen Species in Paraquat-Mediated Dopaminergic Cell DeathAntioxidants & Redox Signaling, 2009
- Cerebrospinal fluid selenium and chromium levels in patients with Parkinson's diseaseJournal of Neural Transmission, 1998
- No evidence for systemic oxidant stress in Parkinson's or Alzheimer's diseaseMovement Disorders, 1995